Cullinan Therapeutics Inc. (CGEM)
NASDAQ: CGEMHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
CGEM stock chart
Technical analysisKey statistics
All statistics- Market cap
- $960.59M
- EPS (TTM)
- -$3.11
- Dividend yield
- None
- 52-week range
- 5.85 – 23.19
- Day range
- 15.47 – 16.44
- Volume / Avg
- 808.18K / 868.12K
- Beta
- —
- Shares outstanding
- 61.46M
- Next earnings
- Nov 5, 2026
52-week range
CGEM stock today
Cullinan Therapeutics (CGEM) closed at $15.63 on Oct 7, down 3.82% (-$0.62), versus the S&P 500's 0.22% decline. At this level, CGEM sits in the middle of its 52-week range of $5.85 to $23.19: 32.6% below the high, set on Aug 26, 2026 and 167.2% above the low. CGEM is up 51.0% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 165.4%.
Cullinan Therapeutics has posted a net loss over the last twelve months (EPS of -$3.11), so its P/E ratio is not meaningful. Cullinan Therapeutics's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Cullinan Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year
- 2021
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-0.79
Cullinan Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| MGTXMeiraGTx Holdings plc | 10.82 | +2.08% | $1.04B | vs CGEM |
| ODTXOdyssey Therapeutics Inc. | 18.08 | -0.28% | $868.90M | vs CGEM |
| GLUEMonte Rosa Therapeutics Inc. | 10.17 | +3.04% | $867.64M | vs CGEM |
| SLBTSL Science Holding Limited | 1.51 | -0.66% | $846.75M | vs CGEM |
| SANASana Biotechnology Inc. | 2.72 | -1.09% | $814.26M | vs CGEM |
| VORVor Biopharma Inc. | 18.78 | +2.57% | $1.11B | vs CGEM |
| IMTXImmatics N.V. | 7.45 | -0.67% | $1.13B | vs CGEM |
| DNAGinkgo Bioworks Holdings Inc. Class A | 11.47 | -7.57% | $772.39M | vs CGEM |
Indexes, lists and sector
Cullinan Therapeutics stock FAQ
What is Cullinan Therapeutics's stock price today?
CGEM last traded at $15.63 as of Oct 7, 4:00 PM EDT, down 3.82% on the day. Prices are delayed at least 15 minutes.
When is Cullinan Therapeutics's next earnings date?
Cullinan Therapeutics is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-0.79.
What is the CGEM 52-week high?
The 52-week high for CGEM is $23.19 and the 52-week low is $5.85. The stock is currently 32.6% below its high.